The Journal of Practical Medicine >
Relationships of prognosis of schizophrenic patients with their serum prolactin and glial fibrillary acid protein
Received date: 2023-04-11
Online published: 2023-09-26
Objective To investigate the relationships of prognosis of schizophrenic patients with their serum prolactin (PRL), glial fibrillary acid protein (GFAP). Methods A total of 128 schizophrenic patients admitted to the hospital from January 2020 to January 2022 were admitted and treated with risperidone in our hospital. The prognostic status of the patients after 12 months of treatment was analyzed, the prognostic factors were explored and the prognostic value of PRL and GFAP were investigated. Results Forty-one patients had poor prognoses. By Logistic multivariate regression analysis, the prognostic factors in the schizophrenic patients were found to include brain-derived neurotrophic factor (BDNF) (OR = 3.931, 95%CI: 1.618 ~ 9.555), nerve growth factor (NGF) (OR = 3.861, 95%CI:1.589 ~ 9.384), PRL (OR = 3.666, 95%CI: 1.508 ~ 8.909) and GFAP (OR = 4.297, 95%CI: 1.768 ~ 10.444) were (P < 0.05). By receiver operating characteristic (ROC) curve analysis, the sensitivities of PRL, GFAP and their combination in predicting the prognoses of the patients were 70.73% (95%CI: 54.26% ~ 83.35%), 73.17% (95%CI: 56.79% ~ 85.25%), and 80.49% (95%CI: 64.63% ~ 90.63%), respectively; the specificities were 75.86% (95%CI: 65.28% ~ 84.12%), 73.56% (95%CI: 62.83% ~ 82.18%), and 87.36% (95%CI: 78.09% ~ 93.22%), respectively; and the AUCs were 0.743 (95%CI: 0.643 ~ 0.843), 0.739 (95%CI: 0.633 ~ 0.845) and 0.884 (95%CI: 0.816 ~ 0.952), respectively. Conclusion PRL combined with GFAP is effective in predicting the prognoses of patients with schizophrenia.
Key words: schizophrenia; prolactin; glial fibrillary acidic protein; prognosis
Na LIU , Tiandao WANG , Chunliu YU , Yi. CHEN . Relationships of prognosis of schizophrenic patients with their serum prolactin and glial fibrillary acid protein[J]. The Journal of Practical Medicine, 2023 , 39(16) : 2090 -2094 . DOI: 10.3969/j.issn.1006-5725.2023.16.013
| 1 | JAUHAR S, JOHNSTONE M, MCKENNA P J. Schizophrenia[J]. Lancet, 2022, 399(10323):473-486. |
| 2 | GASSNER L, GERETSEGGER M, MAYER-FERBAS J. Effectiveness of music therapy for autism spectrum disorder, dementia, depression, insomnia and schizophrenia: update of systematic reviews[J]. Eur J Public Health, 2022, 32(1):27-34. |
| 3 | MA H, CHENG N, ZHANG C. Schizophrenia and Alarmins[J]. Medicina (Kaunas), 2022, 58(6):694-697. |
| 4 | CHAND G B, SINGHAL P, DWYER D B, et al. Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population[J]. Am J Psychiatry, 2022, 179(9):650-660. |
| 5 | KOSKUVI M, LEHTONEN ?, TRONTTI K, et al. Contribution of astrocytes to familial risk and clinical manifestation of schizophrenia[J]. Glia, 2022, 70(4):650-660. |
| 6 | AKKOUH I A, HRIBKOVA H, GRABIEC M, et al. Derivation and Molecular Characterization of a Morphological Subpopulation of Human iPSC Astrocytes Reveal a Potential Role in Schizophrenia and Clozapine Response[J]. Schizophr Bull, 2022, 48(1):190-198. |
| 7 | KINDLER J, LIM C K, WEICKERT C S, et al. Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia[J]. Mol Psychiatry, 2020, 25(11):2860-2872. |
| 8 | 胡淼文, 何丝迪, 沈一峰, 等. 外周血催乳素水平对精神分裂症精神症状和认知功能的影响[J]. 中国神经精神疾病杂志, 2021, 47(5):278-282. |
| 9 | HASAN A, FALKAI P, WOBROCK T, et al. World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - a short version for primary care[J]. Int J Psychiatry Clin Pract, 2017, 21(2):82-90. |
| 10 | BAANDRUP L, ALLERUP P, NIELSEN M O, et al. Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models[J]. Acta Psychiatr Scand, 2022, 146(1):21-35. |
| 11 | 华燕, 吴叶. 认知心理护理对老年精神分裂症患者GAS与PANSS评分的影响[J]. 检验医学与临床, 2020, 17(11):1617-1619. |
| 12 | GERGES S, HADDAD C, DAOUD T, et al. A cross-sectional study of current and lifetime sexual hallucinations and delusions in Lebanese patients with schizophrenia: frequency, characterization, and association with childhood traumatic experiences and disease severity[J]. BMC Psychiatry, 2022, 22(1):360-364. |
| 13 | 李佳, 林荫, 吉训琦, 等. 载脂蛋白E和MTHFR C677T基因多态性与精神分裂症及患者认知功能的关联性[J]. 实用医学杂志, 2021, 37(18):2391-2394. |
| 14 | 曾钢, 肖爱祥, 欧阳艳芳, 等. 稳定期精神分裂症患者病房内综合康复模式的建立与效果评价[J]. 实用医学杂志, 2021, 37(12):1626-1630. |
| 15 | DI BIASE M A, GEAGHAN M P, REAY W R, Et al. Cell type-specific manifestations of cortical thickness heterogeneity in schizophrenia[J]. Mol Psychiatry, 2022, 27(4):2052-2060. |
| 16 | BAUMINGER H, GAISLER-SALOMON I. Beyond NMDA Receptors: Homeostasis at the Glutamate Tripartite Synapse and Its Contributions to Cognitive Dysfunction in Schizophrenia[J]. Int J Mol Sci, 2022, 23(15):8617-8620. |
| 17 | RODRIGUES-AMORIM D, RIVERA-BALTANáS T, DEL CARMEN VALLEJO-CURTO M, et al. Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia[J]. Sci Rep, 2020, 10(1):14271-14274. |
| 18 | RANGANATHAN M, RAHMAN M, GANESH S, et al. Analysis of circulating exosomes reveals a peripheral signature of astrocytic pathology in schizophrenia[J]. World J Biol Psychiatry, 2022, 23(1):33-45. |
| 19 | MARTINEZ-ALARCON O, GARCIA-LOPEZ G, GUERRA-MORA J R,et al. Prolactin from Pluripotency to Central Nervous System Development[J]. Neuroendocrinology, 2022, 112(3):201-214. |
| 20 | COSTA-BRITO A R, GON?ALVES I, SANTOS C R A. The brain as a source and a target of prolactin in mammals[J]. Neural Regen Res, 2022, 17(8):1695-1702. |
| 21 | 侯钦强, 郎小娥, 梁瑛, 等. 首发精神分裂症病人言语性幻听与血清泌乳素水平的相关性分析[J]. 中西医结合心脑血管病杂志, 2022, 20(12):2285-2289. |
/
| 〈 |
|
〉 |